Deborah Matzura‐Wolfe

Statistics

Publications

Citations

466

H-Index

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Henry Ford Hospital

Duke University

St. Luke's Hospital

University of California, Irvine

Deborah Matzura‐Wolfe is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and psychopharmacology.

Publications per year

1995–2017

Publications

A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks

Mark S. Kramer, Deborah Matzura‐Wolfe, A. Polis et al. · Neurology · 1998 · 147 citations

Medicine, Pharmacology, Pharmacotherapy +10

A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder

Mark S. Kramer, Neal R. Cutler, James C. Ballenger et al. · Biological Psychiatry · 1995 · 117 citations

Medicine, Pharmacology, Psychiatry +14

Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials

W. Joseph Herring, Kathleen M. Connor, Ellen Snyder et al. · Journal of Clinical Sleep Medicine · 2016 · 82 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials

W. Joseph Herring, Ellen Snyder, Jill Hutzelmann et al. · American Journal of Geriatric Psychiatry · 2017 · 74 citations

Pharmacy, Pharmacology, Pharmacotherapy +10

Pharmacokinetics of Rizatriptan Tablets During and Between Migraine Attacks

Neal R. Cutler, Stanford S. Jhee, Anup Majumdar et al. · Headache The Journal of Head and Face Pain · 1999 · 28 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +10

1–5 of 6